arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Forum Markets, Incorporated

FRMM Health Care Biotechnology: Pharmaceutical Preparations
$5.99
▲ +5.1% Today
as of Jul 22, 16:49 ET
Last 30 days +6.54% Jun 12 → Jul 22
$4.89 $5.40 $5.92 $6.44 $6.95 Jun 12 Jun 22 Jun 29 Jul 08 Jul 15 Jul 22
Open
$4.75
High
$5.19
Low
$4.75
Volume
$655,229
Avg Vol
$1M
Mkt Cap
$81M
P/E (TTM)
—
Beta
—
52w High
$174.60
52w Low
$1.76
Div Yield
—
Shares Out
$20M

Recent Press Releases & News last 60 days · 2 items

Jun 30 · 11:31 MT Newswires
Forum Markets Lowers Share Buyback Authorization to $100 Million From $250 Million
Jun 27 · 16:07 Simply Wall St.
Forum Markets (FRMM) Stock Sees Fair Value Lift As Analysts Back Tokenization Shift

Overview

52-week range
$1.76
$175
2% of range
Avg surprise (last 0)
—
Avg reaction (last 3)
+6.1%
100% positive
Latest IV / EM
174%
EM ±39.9% · $5 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-24.53$-18.39$-12.26$-6.12$0.01 Actual $-13.37Actual $-24.53Actual $-1.68Actual $0.01Actual $-5.43Actual $-0.67Actual $-0.30Actual $-16.80Actual $-3.64 JunSepMarJunSepMar/2025Jun/2025SepMar/2026
Revenue vs Net Income Revenue Net income
$-217M$-161M$-106M$-51M$4M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-3.64 — — -443.3% +9.2% earnings
Tue Sep 30, 2025Sep 2025 $-16.80 — — — — financials
Wed Jul 23, 2025Jun/2025 $-0.30 — — — +3.6% earnings
Thu May 15, 2025Mar/2025 $-0.67 — — — +5.4% earnings
Mon Sep 30, 2024Sep 2024 $-5.43 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.01 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.68 — — — — financials
Sat Sep 30, 2023Sep 2023 $-24.53 — — — — financials
Fri Jun 30, 2023Jun 2023 $-13.37 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Jul 22, 2026Jun/2026OTHER -$0.21$3.00 -107.0%

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$3M—$4M—————
Cost of revenue————————
Gross profit————————
Operating income$-5M—$-220M$-2M$-2M—$-596,172$-2M
Net income$-76M—$-217M$-2M$-2M—$-836,720$11,781
EPS (diluted)$-3.64—$-16.80$-0.30$-5.54—$-5.43$0.01

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$66M$8M$53M——$5M——
Inventory————————
Total current assets$83M$14M$562M$3M$4M$5M$1M$2M
Total assets$208M$306M$1.01B$11M$12M$13M$10M$4M
Long-term debt————————
Total liabilities$39M$67M$564M$5M$4M$4M$7M$4M
Total equity$168M$239M$445M$5M$8M$9M$4M$-417,987

Implied volatility — last 90 days

86%239%391%543%696% Jun 07 — IV 181% · EM ±25.0%Jun 08 — IV 171% · EM ±22.6%Jun 09 — IV 180% · EM ±22.5%Jun 10 — IV 208% · EM ±24.6%Jun 11 — IV 222% · EM ±24.6%Jun 12 — IV 219% · EM ±22.4%Jun 15 — IV 208% · EM ±15.1%Jun 16 — IV 341% · EM ±20.2%Jun 17 — IV 118% · EM ±4.9%Jun 19 — IV 99% · EM ±21.8%Jun 22 — IV 102% · EM ±21.3%Jun 23 — IV 100% · EM ±20.4%Jun 24 — IV 108% · EM ±21.7%Jun 25 — IV 98% · EM ±19.2%Jun 26 — IV 87% · EM ±16.6%Jun 29 — IV 219% · EM ±38.8%Jun 30 — IV 163% · EM ±28.1%Jul 01 — IV 216% · EM ±36.0%Jul 02 — IV 149% · EM ±24.1%Jul 03 — IV 154% · EM ±24.1%Jul 06 — IV 233% · EM ±32.2%Jul 07 — IV 193% · EM ±25.4%Jul 08 — IV 224% · EM ±28.1%Jul 09 — IV 222% · EM ±26.3%Jul 10 — IV 209% · EM ±23.1%Jul 13 — IV 395% · EM ±33.0%Jul 14 — IV 461% · EM ±33.4%Jul 15 — IV 595% · EM ±35.1%Jul 16 — IV 696% · EM ±29.1%Jul 20 — IV 201% · EM ±47.4%Jul 21 — IV 177% · EM ±41.2%Jul 22 — IV 174% · EM ±39.9%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,162.23-0.1%
JNJ
Johnson & Johnson
$601.7B $255.02-0.2%
ABBV
AbbVie Inc.
$447.7B $256.20+1.1%
MRK
Merck & Company, Inc.
$307.2B $127.47-0.0%
PM
Philip Morris International Inc
$300.4B $195.00+0.3%
NVS
Novartis AG
$293.4B $152.73-0.2%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in